Clinical laboratory tests have no value if clinicians cannot quickly order and obtain the results they need. We found that efforts to obtain even the most commonly ordered tests are often derailed by excessively complex nomenclature. Ordering the right laboratory tests is critical to diagnosis and treatment, but existing mechanisms for entering lab orders actively interfere with physicians' efforts to provide good clinical care. Rather than simplifying lab orders, the advent of computerized physician order entry (CPOE) systems-generally programmed by non-clinicians-has introduced new and vexing practical problems. Medical laboratories have filled their test menus, whether paper or electronic, with bewildering nomenclature and abbreviations, and have failed to appreciate the dangers of assigning perilously similar names to different tests. The efficient and efficacious patient care demanded by the quality care initiative requires progress beyond traditional solutions, such as convening naming conventions, to the development of innovative software with intelligent, real-time, clinically driven search functions that will allow these programs to help rather than hinder physicians.
INTRODUCTION
This publication is the outcome of the Clinical Laboratory Integration into Healthcare Collaborative (CLIHC) TM , a workgroup established by the Centers for Disease Control and Prevention (CDC). The CDC convened seven Institutes from 1984 to 2007 on critical issues in clinical laboratory practice (http://wwwn.cdc.gov/dls/institutes/), bringing together national and international experts to focus on the role of the laboratory in providing quality testing for improving patient outcomes. CDC had established several workgroups of laboratory and healthcare experts to address the Institutes' recommendations. The topic of this paper has been identified by these experts as a clinically significant factor affecting patient outcomes.
The optimal selection of clinical laboratory tests is an important contributor to accurate diagnosis and patient care. [1] [2] [3] Central to this process is the physician's ability to correctly decipher laboratory test nomenclature as seen on an order entry screen or requisition, so that she can correctly order the best possible test(s). Physicians believe this is important. A recent CDC survey investigated internal medicine and family medicine physicians' access to electronic assistance in ordering appropriate laboratory tests. While only 10 % of the physicians surveyed had such electronic access, 60 % of that group, using a five point Likert scale, rated the electronic suggestions to be "very" to "extremely useful." (Unpublished observations from 2012 CDC national survey)
The examples of the problems provided above illustrate the confusion between several commonly ordered tests. Centers for Medicare & Medicaid Services (CMS) Medicare Part B clinical laboratory claims (2009, obtained by CDC) demonstrate the potential magnitude of the problem. In the 2009 claims data, there were 26.1 million basic metabolic profiles (BMP) and 1.1 million brain naturetic peptide (BNP), 2.4 million C-reactive protein (CRP) and 13,000 Protein C, and 17,000 lactic acid and 19.9 million lactate dehydrogenase.
A variety of difficulties arise in the ordering process.
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We believe we have identified two root causes of these problems: the multiplicity of names and abbreviations used for a given laboratory test; and the complexity of the test nomenclature itself, including the absence of a standardized naming protocol, resulting in inappropriate or inaccurate names for tests. A recent study showed incorrect test ordering as a major contributor to errors in diagnosis and a major driver of escalating costs in health care. 7 One scenario occurs when the test ordered is inappropriate, e.g., the test selected is incorrect or unnecessary. 8 In other instances, nomenclature The lists of tests are illustrative, not comprehensive. Assays for this report were selected on the basis of common usage and nomenclature complexity. The common name was selected by author consensus and does not reflect any official designation, as no international consensus exists except where indicated by specific references.
How We Got Here
In the CDC survey of physicians' challenges mentioned above, over half of respondents found the multiplicity of names of laboratory tests to be "somewhat" to "extremely problematic." Ordering a laboratory test engages a very intricate process that presents challenges to the laboratory practitioners offering the service and the physicians ordering the appropriate test(s). Figure 1 uses Vitamin D to illustrate the process. With multiple clinical laboratory assay names representing identical, similar or related analytes, local laboratory personnel propose tests, names and abbreviations, and then pare options to fit a laboratory requisition or computerized order entry form. The laboratory information system (LIS) coder then selects or creates representative names, abbreviations and mnemonics that fit within LIS vendor parameters. Correct test selection, and ultimately patient outcome, relies on limited expert consensus, local laboratory personnel, coder selections, clinician reasoning, and characteristics of order entry. Table 1 demonstrates the variability in laboratory test nomenclature for the same test and the major challenge faced by physicians in ordering laboratory tests. In some cases, the test name is based upon the disease with which it is associated. An example is rheumatoid factor, an antibody that was discovered to be associated with rheumatoid arthritis and inappropriately named for the disease, even though it is neither highly sensitive nor highly specific for this condition. 10 However, the test name suggests a definitive diagnosis, when in actuality, at best, the laboratory result may just support a clinical impression formed by the physician.
Hemoglobin A1c
Hgb A1c Test names can also reflect a reagent used in the performance of the test. While anticardiolipin antibodies (ACA) are named for cardiolipin, a reagent used in screening tests for syphilis and first extracted from animal hearts, ACA tests are performed to try to determine if the cause of unexplained thrombosis or repeated miscarriages is antiphospholipid syndrome.
Other methods of naming tests include those based on the name of its developer. A well-known example is the Lowry assay for quantitation of protein, named after Dr. Oliver Lowry. Test names are sometimes associated with the person who was first described as having a disease. Coagulation factor XII deficiency is also known as Hageman factor deficiency, after John Hageman who was found to be deficient in factor XII.
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There are also often multiple abbreviations for individual laboratory tests. Much of the variation can be attributed to laboratory information systems (LIS) that identify a laboratory test by providing unique abbreviations based upon the number of characters permitted by the system, a complicated, arbitrary and non-standardized process. Over time, laboratory personnel began to use their LIS abbreviations when reporting test results. Physicians using that laboratory in turn started associating the LIS abbreviations with certain tests. The abbreviations have become part of the vernacular; so both the laboratorian and physician may talk about ordering an FBS, or FGLU, FGLUC, GLUF, FG, etc. rather than saying "fasting glucose". The abbreviations may be so different as to not match anything a physician has seen from one health care setting to another. 12 Therefore, the physician might not know which test abbreviation represents something as simple as a serum glucose.
The lack of naming convention adds complications to ordering one of the most common of test panels, the complete blood count (CBC) with differential. As seen in the list of synonyms in Table 1 , the CBC test panel name may or may not include a particular component, e.g., the platelet count or even the white blood cell (WBC) differential itself. In addition, the components of a differential vary between laboratories, leading to discrepancies between what a physician thought she ordered and the results she received. Only trial and error would tell the physician what the test name really included.
Lupus anticoagulant is another example of inappropriate test naming. The test is not for an anticoagulant. It is actually a procoagulant, and is primarily found in patients who do not have systemic lupus erythematosus (SLE). Table 1 also illustrates the multitude of synonyms in use for this test, most of which still do not adequately describe the relationship between the test and the disorder.
The problem is exacerbated by the "mapping" of laboratory tests to electronic medical records programs. In this process, laboratory directors decide how their tests' natural-language nomenclature or LIS names will be linked to what will appear on the test menu. Depending on those decisions, mapping may be as simple as one-to-one; or as complex as one-to-many, many-to-one, or many-to-many (see Fig. 2 ).
Why It Hasn't Been Fixed. The complexity of laboratory test names and abbreviations compromises the physician's ability to appropriately utilize laboratory services, delays patient care and wastes health care resources. To resolve the confusion, consensus conferences have occasionally been convened to reduce the number of different names for tests. [13] [14] [15] Such an endeavor occurred in the switch of names for coagulation factors. 16 These were originally named for the person first identified with the deficiency of a particular coagulation factor; subsequently, each factor was identified with a discreet Roman numeral. Most often, however, no consensus conference to address unwanted diversity in nomenclature has been held, or if it was, the recommended name change failed to be incorporated into clinical practice. In addition, the proliferation of molecular methods and genetic studies in medicine has expanded the number of stakeholders that would have to be brought to the table with each standardization effort. Even if consensus could be reached by multiple stakeholders today, the nomenclature would become obsolete with a next round of scientific research.
Two other major efforts to standardize nomenclature have been made: Logical Observation Identifier Names and Codes (LOINC) and Systematized Nomenclature of Medicine (SNOMED)-Clinical Terms. LOINC was developed by the Regenstrief Institute in the 1990's, as "a database to facilitate the exchange and pooling of results for clinical care, outcomes management, and research." [17] [18] [19] [20] [21] SNOMED, created by the College of American Pathologists in 1965 as logic-organized codes for key pathology terms, was later expanded to include terminology for the entire medical record. 22, 23 Both are systems for data exchange between electronic information systems 24 ; neither was designed to facilitate clinical decision making to order laboratory tests.
Future Directions
Appropriate laboratory ordering could be greatly aided by using sophisticated search technology, as seen with BING and GOOGLE, which in many ways emulate the way people "think." Such tools present multiple, related options to an individual who is searching for a word or phrase. Advanced computational machine learning methods, such as Bayesian Network or Markov Decision Support, would be able to interpret the type of clinician, patient and patient conditions and intelligently identify the most likely tests. The technology might seek and "offer" possibilities in ranked order of likelihood, much as the familiar query:"-Did you mean…?" Using interactive design fundamentals, the support would include inherent feedback, such as identifying the individual tests included in a BMP, conditions that might either preclude the ordering of the test or affect the interpretation of the results, and potential alternatives. The interface would support, not automate, clinicians' thought processes. The underlying logic of the system must be robust and meet very high levels of certainty. 25 The goal is to have an interface the clinician finds convenient, "respectful," flexible and fast in helping to identify and then order the correct laboratory test(s). In other words, it should be as close to the type of interaction the clinician would expect from a knowledgeable and helpful human. This type of interaction involves a number of different analytic domains that humans perform relatively seamlessly (if not accurately or consistently).
A search engine-like approach would continuously update itself as it "learns" and recalculates the rank or weight of a term, criteria and/or assumption. The approach would eliminate the need for mandatory changes or standardizations that might become obsolete with new advances in the science of medicine. Future work of CLIHC TM will examine the principles and domains of this form of communication and interconnectibility as they pertain to the needs of physicians and patients utilizing medical laboratory services.
